Technical Analysis for AKRO - Akero Therapeutics, Inc.

Grade Last Price % Change Price Change
C 45.36 -1.22% -0.56
AKRO closed down 1.22 percent on Monday, September 25, 2023, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Oct 1
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 6 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Down 2 % about 9 hours ago
200 DMA Support about 10 hours ago
200 DMA Resistance about 10 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Steatohepatitis Hepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease

Is AKRO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.38
52 Week Low 26.37
Average Volume 706,695
200-Day Moving Average 45.65
50-Day Moving Average 46.76
20-Day Moving Average 49.60
10-Day Moving Average 49.52
Average True Range 1.94
RSI (14) 35.90
ADX 26.47
+DI 22.63
-DI 27.16
Chandelier Exit (Long, 3 ATRs) 47.94
Chandelier Exit (Short, 3 ATRs) 50.82
Upper Bollinger Bands 52.91
Lower Bollinger Band 46.29
Percent B (%b) -0.14
BandWidth 13.35
MACD Line 0.13
MACD Signal Line 0.82
MACD Histogram -0.6889
Fundamentals Value
Market Cap 1.57 Billion
Num Shares 34.7 Million
EPS -91.75
Price-to-Earnings (P/E) Ratio -0.49
Price-to-Sales 0.00
Price-to-Book 3.39
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.79
Resistance 3 (R3) 46.82 46.38 46.55
Resistance 2 (R2) 46.38 46.02 46.36 46.47
Resistance 1 (R1) 45.87 45.79 45.65 45.84 46.39
Pivot Point 45.43 45.43 45.32 45.41 45.43
Support 1 (S1) 44.92 45.07 44.70 44.89 44.33
Support 2 (S2) 44.48 44.84 44.46 44.25
Support 3 (S3) 43.97 44.48 44.17
Support 4 (S4) 43.94